Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Hold
3,266
0.31% 64
2026
Q1
$401K Hold
3,266
0.35% 62
2025
Q4
$378K Hold
3,266
0.32% 63
2025
Q3
$299K Hold
3,266
0.28% 66
2025
Q2
$262K Hold
3,266
0.27% 72
2025
Q1
$272K Sell
3,266
-15
-0.5% -$1.4K 0.31% 68
2024
Q4
$286K Buy
+3,281
New +$338K 0.31% 69

Other funds holding MRK

RD Lewis Holdings's MRK Position: Q2 2026 in Review

RD Lewis Holdings held its Merck (MRK) position steady in Q2 2026 at 3,266 shares worth $425K. The position accounts for 0.31% of the portfolio, ranked #64.

RD Lewis Holdings first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • RD Lewis Holdings held 3,266 shares of Merck worth $425K as of Q2 2026.
  • RD Lewis Holdings left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.31% of RD Lewis Holdings's portfolio in Q2 2026, its #64 holding.
  • RD Lewis Holdings first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on RD Lewis Holdings's 13F filing for Q2 2026, filed 12 Aug 2026.